Being invited to present research at an international academic conference is an honor for any seasoned professional. But for ...

Use of AI can be a controversial subject, but in many ways, it's improving patient's experiences and helping doctors detect problems they can't see with the human eye.

As of Friday, February 27, Fulgent Genetics, Inc.’s FLGT share price has dipped by 31.34%, which has investors questioning if this is right time to buy.

Cognizant CAIO Babak Hodjat on agentic AI, sovereign compute, and how India’s AI ecosystem can scale through infrastructure, design, and collaboration, interview ...

Stephen Whitelam, a researcher whose work spans thermodynamic theory and machine learning, has described a framework for ...

A new report shows that agricultural corporations and big tech is pricing innovation out of reach of smallholder farmers who ...

Rare disease is a major – and growing – area of clinical research and drug development. Of the FDA’s 46 novel drug approvals ...

People with aphantasia have no mental imagery—and they’re offering brain scientists a window into consciousness ...

Illumina, Inc. (NASDAQ: ILMN) today announced the launch of TruPath™ Genome, setting a new standard for high-quality, ...

With an incredibly simple workflow, TruPath Genome eliminates traditional library prep. In just 10-15 minutes of hands-on ...